Switch theme
Sign up to access all valuation multiples
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
1923
34K+
LTM Revenue $20.2B
LTM EBITDA $5.0B
$82.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Colgate-Palmolive has a last 12-month revenue (LTM) of $20.2B and a last 12-month EBITDA of $5.0B.
In the most recent fiscal year, Colgate-Palmolive achieved revenue of $20.1B and an EBITDA of $4.9B.
Colgate-Palmolive expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Colgate-Palmolive valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $20.2B | XXX | $20.1B | XXX | XXX | XXX |
| Gross Profit | $12.2B | XXX | $12.2B | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 60% | XXX | XXX | XXX |
| EBITDA | $5.0B | XXX | $4.9B | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 24% | XXX | XXX | XXX |
| EBIT | $4.3B | XXX | $4.3B | XXX | XXX | XXX |
| EBIT Margin | 21% | XXX | 22% | XXX | XXX | XXX |
| Net Profit | $3.0B | XXX | $2.9B | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $6.9B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Colgate-Palmolive's stock price is $93.
Colgate-Palmolive has current market cap of $75.3B, and EV of $82.5B.
See Colgate-Palmolive trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $82.5B | $75.3B | XXX | XXX | XXX | XXX | $3.62 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Colgate-Palmolive has market cap of $75.3B and EV of $82.5B.
Colgate-Palmolive's trades at 4.1x EV/Revenue multiple, and 17.0x EV/EBITDA.
Equity research analysts estimate Colgate-Palmolive's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Colgate-Palmolive has a P/E ratio of 25.4x.
See valuation multiples for Colgate-Palmolive and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $75.3B | XXX | $75.3B | XXX | XXX | XXX |
| EV (current) | $82.5B | XXX | $82.5B | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | 16.6x | XXX | 17.0x | XXX | XXX | XXX |
| EV/EBIT | 19.1x | XXX | 19.0x | XXX | XXX | XXX |
| EV/Gross Profit | 6.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 25.4x | XXX | 26.1x | XXX | XXX | XXX |
| EV/FCF | 24.5x | XXX | 23.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialColgate-Palmolive's last 12 month revenue growth is 2%
Colgate-Palmolive's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Colgate-Palmolive's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Colgate-Palmolive's rule of X is 30% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Colgate-Palmolive and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | 24% | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 30% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Colgate-Palmolive acquired XXX companies to date.
Last acquisition by Colgate-Palmolive was XXXXXXXX, XXXXX XXXXX XXXXXX . Colgate-Palmolive acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Colgate-Palmolive founded? | Colgate-Palmolive was founded in 1923. |
| Where is Colgate-Palmolive headquartered? | Colgate-Palmolive is headquartered in United States of America. |
| How many employees does Colgate-Palmolive have? | As of today, Colgate-Palmolive has 34K+ employees. |
| Who is the CEO of Colgate-Palmolive? | Colgate-Palmolive's CEO is Mr. Noel R. Wallace. |
| Is Colgate-Palmolive publicy listed? | Yes, Colgate-Palmolive is a public company listed on NYS. |
| What is the stock symbol of Colgate-Palmolive? | Colgate-Palmolive trades under CL ticker. |
| When did Colgate-Palmolive go public? | Colgate-Palmolive went public in 1951. |
| Who are competitors of Colgate-Palmolive? | Similar companies to Colgate-Palmolive include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Colgate-Palmolive? | Colgate-Palmolive's current market cap is $75.3B |
| What is the current revenue of Colgate-Palmolive? | Colgate-Palmolive's last 12 months revenue is $20.2B. |
| What is the current revenue growth of Colgate-Palmolive? | Colgate-Palmolive revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Colgate-Palmolive? | Current revenue multiple of Colgate-Palmolive is 4.1x. |
| Is Colgate-Palmolive profitable? | Yes, Colgate-Palmolive is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Colgate-Palmolive? | Colgate-Palmolive's last 12 months EBITDA is $5.0B. |
| What is Colgate-Palmolive's EBITDA margin? | Colgate-Palmolive's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Colgate-Palmolive? | Current EBITDA multiple of Colgate-Palmolive is 16.6x. |
| What is the current FCF of Colgate-Palmolive? | Colgate-Palmolive's last 12 months FCF is $3.4B. |
| What is Colgate-Palmolive's FCF margin? | Colgate-Palmolive's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Colgate-Palmolive? | Current FCF multiple of Colgate-Palmolive is 24.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
